Xenon Pharmaceuticals (XENE) EPS (Weighted Average and Diluted): 2013-2025
Historic EPS (Weighted Average and Diluted) for Xenon Pharmaceuticals (XENE) over the last 9 years, with Sep 2025 value amounting to -$1.15.
- Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) fell 41.98% to -$1.15 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.89, marking a year-over-year decrease of 37.94%. This contributed to the annual value of -$3.01 for FY2024, which is 10.26% down from last year.
- Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$1.15 in Q3 2025, which was down 7.48% from -$1.07 recorded in Q2 2025.
- Over the past 5 years, Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at -$0.35 during Q1 2022, and registered a low of -$1.15 during Q3 2025.
- In the last 3 years, Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.75 in 2024 and averaged -$0.80.
- In the last 5 years, Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) plummeted by 80.00% in 2023 and then rose by 1.59% in 2024.
- Xenon Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.48 in 2021, then fell by 18.75% to -$0.57 in 2022, then declined by 12.28% to -$0.64 in 2023, then plummeted by 31.25% to -$0.84 in 2024, then slumped by 41.98% to -$1.15 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.15 for Q3 2025, versus -$1.07 for Q2 2025 and -$0.83 for Q1 2025.